'Cobra Venom' Painkiller Co. Inks Deal To Settle SEC Claims

By Emilie Ruscoe · March 15, 2024, 6:47 PM EDT

A penny stock company that previously held itself out as a maker of cobra venom-infused pain drugs has agreed to resolve U.S. Securities and Exchange Commission fraud claims, according to court...

To view the full article, register now.